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Background: High mean corpuscular volume (MCV) has been implicated in various health problems, such as ane-
mia, liver disease, and thyroid disease. However, the clinical significance of borderline-high MCV is poorly under-
stood in the primary care setting. This study aimed to investigate whether borderline-high MCV was related to arte-
rial stiffness in Korean adults as measured by brachial-ankle pulse wave velocity (baPWV).
Methods: This cross-sectional study comprised 582 participants aged >30 years who underwent routine health ex-
aminations. Borderline-high MCV was defined as over 95.0 fl (>90th percentile) after excluding participants with 
MCV of ≥100 fl or ≤80 fl, and high baPWV was defined as >1,600 cm/s (>90th percentile). The odds ratios (ORs) and 
95% confidence intervals (CIs) for high baPWV according to borderline-high MCV were calculated using multiple 
logistic regression analyses after adjusting for the confounding variables.
Results: The mean age of the study population was 47.8±11.7 years, and 56.9% of the participants were male. Com-
pared to that in the control group, the OR (95% CI) of high baPWV in those with a borderline-high MCV was 3.68 
(1.39–9.74) after adjusting for age, sex, body mass index, alcohol intake, smoking status, regular exercise, mean 
blood pressure, fasting plasma glucose, triglyceride, high-density lipoprotein cholesterol, C-reactive protein, 
γ-glutamyltransferase, uric acid, hypertension medication, and diabetes medication.
Conclusion: Borderline-high MCV was independently associated with arterial stiffness among apparently healthy 
Korean individuals.
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INTRODUCTION
High mean corpuscular volume (MCV), also known as macrocytosis, 
is associated with vitamin B12 and folic acid deficiency, liver disease, 
hyperglycemia, alcoholism, smoking habits, and other pathologic con-
ditions.1,2) Moreover, a high MCV is associated with increased all-cause 
mortality and cancer mortality in non-anemic cancer-free individu-
als.3)
 Pulse wave velocity (PWV) is one of various markers of early arterial 
wall changes such as arterial wall thickness and stiffness.4) It is defined 
as the velocity of blood streaming from the heart to peripheral arteries 
through the aorta and is known to increase with blood vessel stiff-
ness.5,6) Brachial-ankle pulse wave velocity (baPWV) is also strongly 
correlated with aortic PWV and can be used as a simple, noninvasive, 
and automatic method to measure arterial stiffness in the primary care 
setting.7) Previous studies have shown that increased PWV is indepen-
dently associated with cardiovascular disease (CVD) incidence and 
mortality. Moreover, high baPWV was a strong predictor of early carot-
id atherosclerosis.8) A baPWV of >1,400 cm/s is an independent risk 
factor for moderate risk (≥10%) stratification according to the Fram-
ingham risk scoring system, and a baPWV of >1,600 cm/s is an inde-
pendent factor for high risk stratification according to the European 
systematic coronary risk evaluation (SCORE) system.9)
 Although high MCV has been implicated in various health prob-
lems, the clinical significance of borderline-high MCV is poorly under-
stood among apparently healthy Korean individuals in the primary 
care setting. Therefore, this study aimed to examine whether border-




Medical records of 641 participants who voluntarily underwent a 
medical examination including baPWV measurement at the Health 
Promotion Center of Gangnam Severance Hospital in Seoul, Korea, 
between October 2007 and July 2010 were reviewed. Participants 
meeting any of the following criteria were excluded (n=59): MCV, ≥100 
fl or ≤80 fl; white blood cell (WBC) count, ≥10.0 (×103 cells/μL); and 
high-sensitivity C-reactive protein (hsCRP), ≥3.0 mg/L. After excluding 
non-eligible participants, 582 participants were finally enrolled into 
the final analysis. This study was conducted in accordance with the 
ethical principles of the Declaration of Helsinki and was approved by 
the Institutional Review Board of Yonsei University College of Medi-
cine, Seoul, Korea (IRB approval no., 3-2019-0098). Informed consent 
was obtained from all individual participants included in the study.
2. Data Collection
Participants were asked about their lifestyle, including smoking habits, 
alcohol consumption, and physical activity (more or less than 2 times 
per week), as well as their medical conditions with the date of diagno-
sis and current medications. Trained staff reviewed the completed 
questionnaires and recorded the responses into a database. Partici-
pants were classified as non-smokers, ex-smokers, or current smokers. 
Alcohol drinking was defined as consumption of more than 2 times 
per week. Regular exercise was defined as exercise of more than 2 
times per week. Body mass index (BMI) was calculated as weight di-
vided by height squared (kg/m2). Blood samples were collected after a 
12-hour overnight fast. WBC counts and red blood cell indices were 
quantified by an automated blood cell counter (ADVIA 120; Bayer 
Corp., Tarrytown, NY, USA). Borderline-high MCV was defined as 
≥95.0 fl and <100 fl based on previous epidemiological studies (>90th 
percentile).1,3) Fasting plasma glucose, total cholesterol, triglycerides, 
high-density lipoprotein (HDL) cholesterol, hsCRP, γ-glutamyltrans-
ferase, and uric acid were measured using a Hitachi 7600-110 Chemis-
try Autoanalyzer (Hitachi, Tokyo, Japan). The mean blood pressure 
was calculated using the following equation: (systolic blood pressure+ 
diastolic blood pressure×2)/3.
3. Brachial-Ankle Pulse Wave Velocity Measurement
As previously reported,5,8,10,11) baPWV was measured and calculated 
using an automatic waveform analyzer (model BP-203RPE; Colin Co., 
Komaki, Japan). This instrument simultaneously recorded venous 
blood pressure, phonocardiogram, electrocardiogram, and arterial 
blood pressure in both upper arms and ankles. Participants were ex-
amined in supine position after at least 10 minutes of rest. Pneumatic 
cuffs were connected to sensors and wrapped around both upper 
arms and ankles. Waveforms were obtained from brachial and tibial 
arteries. For each measurement, 10-second sample times with auto-
matic gain analysis and quality adjustment were obtained. The time 
interval (ΔT) between the arm and ankle distance was defined as the 
pulse transit time between the brachial and tibial arterial pressure 
waveforms. L was defined as the difference between the distance from 
the heart to the upper arm and the distance from the heart to the ankle 
and was automatically estimated based on participants’ heights. BaP-
WV was calculated using the following equation: baPWV=L/ΔT. BaP-
WV of >1,400 cm/s and >1,600 cm/s are known independent variables 
for risk stratification according to the Framingham risk and SCORE 
risk scores, respectively.7,9) In this regard, high baPWV, a surrogate in-
dicator for arterial stiffness, was defined as >1,600 cm/s in this study, 
which corresponded to the 90th percentile.
4. Statistical Analysis
The Student t-test and chi-square test were used to compare demo-
graphic and biochemical characteristics of the study population ac-
cording to borderline-high MCV for continuous and categorical vari-
ables, respectively. Univariate analysis was performed to evaluate the 
relationship between arterial stiffness and several cardiovascular risk 
factors. Analysis of covariance was also used to verify differences in 
mean baPWV according to the borderline-high MCV after adjusting 
for age, sex, BMI, hsCRP, hypertension medication, and diabetes med-
ication.
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 The odds ratios (ORs) for high baPWV were calculated using multi-
variate logistic regression analysis after adjusting for confounding vari-
ables according to borderline-high MCV. All analyses were conducted 
using SAS statistical software ver. 9.4 (SAS Institute Inc., Cary, NC, 
USA). All statistical tests were two-sided, and statistical significance 
was determined at a P-value of <0.05.
RESULTS
Table 1 shows the clinical characteristics of the study population (330 
men and 252 women). The mean age and BMI were 47.8±11.7 years 
and 23.8±2.9 kg/cm2, respectively. The mean systolic and diastolic 
blood pressure were 119.5±15.2 mm Hg and 73.1±11.9 mm Hg, respec-
tively. The proportion of participants with borderline-high MCV was 
10.5%. Compared with controls, age, male sex, and γ-glutamyltrans-
ferase were higher in the borderline-high MCV group.
 Table 2 shows the univariate analysis between high baPWV and 
some indicators for cardiovascular risk. BaPWV was found to be signif-
icantly associated with age (OR, 1.13; P<0.001), BMI (OR, 1.17; 
P<0.001), systolic blood pressure (OR, 1.08; P<0.001), diastolic blood 
pressure (OR, 1.11; P<0.001), fasting plasma glucose (OR, 1.02; 
P<0.001), hsCRP (OR, 1.43; P<0.001), and borderline-high MCV (OR, 
3.05; P<0.001).
 Figure 1 shows the means and standard errors of baPWV (cm/s) ac-
cording to borderline-high MCV after adjusting for age, sex, BMI, 
hsCRP, hypertension medication, and diabetes medication. The mean 
Table 1. Characteristics of the study population




Age (y) 47.8±11.7 47.3±11.7 52.5±10.5 0.002
Body mass index (kg/m2) 23.8±2.9 23.8±2.9 23.5±2.7 0.586
Male gender 331 (56.9) 295 (55.5) 36 (72.0) 0.023
Current smoker 132 (22.7) 120 (22.6) 12 (24.0) 0.815
Alcohol consumption 420 (71.2) 379 (71.2) 41 (82.0) 0.104
Regular exercise 344 (59.1) 311 (58.5) 33 (66.0) 0.299
Systolic blood pressure (mm Hg) 119.5±15.2 119.4±15.3 120.8±14.4 0.527
Diastolic blood pressure (mm Hg) 73.1±11.9 72.9±12.0 75.5±10.9 0.145
Fasting plasma glucose (mg/dL) 96.2±18.5 96.1±18.9 96.7±14.3 0.784
Triglyceride (mg/dL) 113.7±94.7 112.5±90.2 127.1±134.0 0.453
High-density lipoprotein cholesterol (mg/dL) 48.1±12.6 47.9±12.5 50.1±13.9 0.226
White blood cells (×103 cell/μL) 5.5±1.4 5.5±1.3 5.5±1.6 0.903
C-reactive protein (mg/L) 0.6±0.6 0.6±0.6 0.6±0.7 0.694
γ-glutamyltransferase (U/L) 24.4±16.0 23.7±15.3 32.3±20.6 0.005
Uric acid (mg/dL) 5.2±1.4 5.2±1.4 5.4±1.3 0.198
Hemoglobin (d/dL) 14.6±1.4 14.6±1.4 14.9±1.2 0.197
Hypertension medication 73 (12.5) 70 (13.2) 3 (6.0) 0.144
Diabetes medication 24 (4.1) 23 (4.3) 1 (2.0) 0.429
Values are presented as mean±standard deviation or number (%), unless otherwise stated.
Table 2. Univariate analysis of factors associated with high brachial-ankle pulse 
wave velocity
Variable
High brachial-ankle pulse wave velocity
Odds ratio P-value
Age (y) 1.13 (1.09–1.16) <0.001
Body mass index (kg/m2) 1.17 (1.07–1.28) <0.001
Systolic blood pressure (mm Hg) 1.08 (1.06–1.10) <0.001
Diastolic blood pressure (mm Hg) 1.11 (1.08–1.14) <0.001
Fasting plasma glucose (mg/dL) 1.02 (1.00–1.03) 0.007
Triglyceride (mg/dL) 1.00 (1.00–1.01) 0.016
High-density lipoprotein cholesterol 
(mg/dL)
0.98 (0.96–1.00) 0.082
C-reactive protein (mg/L) 1.43 (1.11–1.84) 0.005
γ-glutamyltransferase (U/L) 1.01 (0.99–1.02) 0.262
Uric acid (mg/dL) 1.01 (0.84–1.22) 0.885
Borderline-high mean corpuscular 
volume (yes or no)
3.05 (1.53–6.08) 0.001
















Figure 1. Mean baPWV according to the presence of borderline-high MCV as 
determined by analysis of covariance analysis adjusted for age, sex, body mass index, 
high-sensitivity C-reactive protein, hypertension medication, and diabetes medication. 
BaPWV, brachial-ankle pulse wave velocity; MCV, mean corpuscular volume.
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baPWV in the borderline-high MCV group was significantly higher 
than that in the control group (1,386.2±22.7 mm Hg versus 1,322.7±8.7 
mm Hg, P=0.024).
 Table 3 shows the ORs for high PWV according to the borderline-
high MCV. The OR (95% CI) of the borderline-high MCV group was 
3.21 (1.22–8.48) after adjusting for age, sex, BMI, alcohol intake, smok-
ing status, regular exercise, systolic blood pressure, diastolic blood 
pressure, fasting plasma glucose, triglyceride, HDL-cholesterol, WBC 
count, C-reactive protein, γ-glutamyltransferase, and uric acid, hyper-
tension medication, and diabetes medication.
DISCUSSION
In this cross-sectional study, borderline-high MCV was independently 
associated with high baPWV. This effect remained even after adjusting 
for potential confounding factors, including the presence of drugs that 
could influence the vascular function. Although the reference value for 
baPWV is different according to age and blood pressure categories,12,13) 
a baPWV of >1,400 cm/s has been shown as a useful predictor of CVD,7) 
and >1,800 cm/s may be a marker of target organ damage.14) Previous 
Korean studies showed that a baPWV of >1,600 cm/s was an indepen-
dent risk factor for greater atherosclerotic disease complexity based on 
the virtual histology intravascular ultrasound analysis and high risk 
stratification based on the SCORE model.9,15)
 Although underlying mechanisms of increased baPWV were not in-
vestigated, some biological mechanisms may help explain the associa-
tion between borderline-high MCV and arterial stiffness. First, in-
creased MCV reflects folate and vitamin B12 deficiencies, which can 
lead to high homocysteine level, a cardiovascular risk factor. Folate 
and vitamin B12 play an important role in regulating the conversion of 
homocysteine. Homocysteine concentrations are strongly negatively 
correlated with folate and vitamin B12 levels.16,17) Homocysteine in-
duces proliferation of smooth muscle cells in the artery, resulting in 
impaired vascular endothelial function and blood coagulability. High 
homocysteine level is thought to contribute to atherosclerosis and in-
creased thickness and blood vessel stiffness.10) Accordingly, lack of fo-
late and vitamin B12 induces elevated MCV and homocysteine levels, 
resulting in elevated arterial stiffness. Second, elevated MCV is an in-
dicator of liver function deterioration, which might be closely related 
to CVD development. Macrocytosis is commonly found in various liv-
er diseases. In individuals with liver disease, the membrane lipid com-
position changes, affecting the membrane surface area, leading to in-
creased MCV. This mechanism depends on the pathogenesis and se-
verity of liver disease.2) Moreover, elevated serum γ-glutamyltrans-
ferase level is strongly associated with increased oxidative stress.18,19) 
Increased oxidative stress induced by decreased liver function is posi-
tively correlated with CVD development.20) Thus, decreased liver func-
tion seems to manifest in elevated MCV as well as arterial stiffness. Fi-
nally, elevated MCV implies thyroid dysfunction, which could also be 
associated with arterial stiffness. Thyroid hormone is involved in the 
regulation of hemoglobin synthesis. MCV values were significantly in-
creased in both overt and subclinical hypothyroidism.21) Moreover, hy-
pothyroidism led to increased vascular resistance and arterial wall 
thickness, which could be attributed to lipid abnormalities, homocys-
teine levels, and abnormal coagulability.22) Therefore, elevated MCV 
and arterial stiffness might be caused by thyroid dysfunction. There-
fore, our findings indicate borderline-high MCV may be accompanied 
by several unfavorable metabolic alterations, which can be implicated 
in increased arterial stiffness.
 Several limitations should be acknowledged in this study. First, the 
causality cannot be concluded due to the cross-sectional design of the 
study. Moreover, other confounding factors affecting baPWV, such as 
thyroid disease, homocysteine levels, and dyslipidemia medication, 
were not considered because these indicators were not fully measured 
at the beginning of this study. Study participants were volunteers visit-
ing for a health promotion screening at a single hospital. Thus, the 
study population appeared to be slightly healthier than community-
based cohorts and may not be representative of the general population 
in Korea, and selection bias may have affected the results.
 In conclusion, we found that borderline-high MCV was indepen-
dently associated with arterial stiffness among apparently healthy Ko-
rean individuals. Further larger-scale prospective cohort studies are 
warranted to validate these associations in the future.
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Table 3. Multiple logistic regression analysis showing the independent contribution of borderline-high MCV to high brachial-ankle pulse wave velocity
Model 1 Model 2 Model 3
OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
Borderline-high MCV 3.05 (1.53–6.08) 0.001 3.08 (1.19–7.98) 0.020 3.21 (1.22–8.48) 0.018
Model 1: unadjusted; model 2: adjusted for age, sex, BMI, alcohol intake, smoking status, regular exercise, SBP, DBP, FPG, triglyceride, HDL-cholesterol, WBC count, CRP, 
γ-glutamyltransferase, and uric acid; model 3: adjusted for age, sex, BMI, alcohol intake, smoking status, regular exercise, SBP, DBP, FPG, triglyceride, HDL-cholesterol, WBC 
count, CRP, γ-glutamyltransferase, uric acid, hypertension medication, and diabetes medication.
MCV, mean corpuscular volume; OR, odds ratio; CI, confidence interval; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma 
glucose; HDL, high-density lipoprotein; WBC, white blood cell; CRP, C-reactive protein.
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